Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5 ... third-shot data would be submitted this week. “The study suggests that a low, 3-microgram ...

All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their ...

Pfizer (PFE) shares jumped higher Thursday after the drugmaker unveiled a $5.3 billion sale of its ... of its application to have its COVID booster shot approved for all American adults.

Pfizer and BioNTech have signed a new $3.2 billion supply contract with the US government for COVID-19 vaccines, covering 105 million doses that may include Omicron-targeted shots. The contract ...

Yes, the Pfizer/BioNTech and Moderna Covid-19 vaccines ... the potential risks under such an emergency situation. That being said, at present, there are still 5 important differences between ...

MINNEAPOLIS — After more than 13 billion COVID vaccines given around the world, the largest studies to date point to the ...

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...

These new shots are ... dose of the Pfizer-BioNTech coronavirus vaccine during an Oakland County Health Department vaccination clinic at the Southfield Pavilion on Aug. 24, 2021, in Southfield, ...

A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines Some 63.8% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna ...

Pfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, ...

The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...

Stock futures rise modestly following a third straight closing record high for the S&P 500; Pfizer and Moderna rise after FDA clears third COVID shot ... futures were up 3 points and Nasdaq ...